Endometriosis, polycystic ovary syndrome (PCOS), and uterine fibroids are highly prevalent gynecologic pathologies that underlie the most common indications
for gynecologic interventions worldwide: pelvic pain, menorrhagia, and infertility.
Our clinical trials
for gynecologic cancers offer patients access to cutting - edge therapies that may not be available anywhere else.
Brian M. Slomovitz, M.D., co-leader of the Gynecologic Cancers Site Disease Group at Sylvester Comprehensive Cancer Center, received the 2018 Presidential Abstract Award from the Society
for Gynecologic Oncology on March 24 during the group's Annual Meeting on Women's Cancer in New Orleans.
«Evidence insufficient regarding screening
for gynecologic conditions with pelvic examination.»
Concern about the safety of electric power morcellation
for gynecologic surgery led the FDA to issue a safety communication in April 2014 discouraging use of the devices and, in November 2014, to recommend against use of morcellation in perimenopausal and postmenopausal women.
Stopping antipsychotic medications, cutting back on marijuana, cocaine, and / or opiates, and limiting nipple stimulation are all ways to stop galactorrhea if these things are found to be the cause, according to Dr. Kevin Audlin of the Institute
for Gynecologic Care at Mercy Medical Center in Baltimore.
This article discusses these effects and makes recommendations
for gynecologic and obstetric care of patients with epilepsy, with particular focus on pregnancy.
Once she starts, your daughter should continue to go
for gynecologic visits every year to keep her informed and healthy.
Not exact matches
From 2003 through 2007, her quarterly column on Current Resources
for Evidence - Based Practice appeared simultaneously in Journal of Midwifery and Women's Health and Journal of Obstetric,
Gynecologic and Neonatal Nursing.
See the certified nurse midwives at The Women's Center
for well woman care, contraceptive options, menopause care, and treatment of problem
gynecologic conditions and diseases.
Wellness visits
for basic, holistic
gynecologic care including pap tests, STI screening, blood tests, sex - positive contraceptive and family planning education and counseling.
WOMENS HEALTH CARE — BY WOMEN,
FOR WOMEN: Make use of our complete range of services: we provide well - woman gynecologic care for every age gro
FOR WOMEN: Make use of our complete range of services: we provide well - woman
gynecologic care
for every age gro
for every age group.
Optimal
gynecologic and obstetric care
for women with epilepsy requires a multidisciplinary approach throughout the various life stages.
The mission of the American College of Nurse - Midwives is to support midwives and advance the practice of midwifery in order to achieve optimal health
for women through their lifespan, with expertise in well woman and
gynecologic care, promoting optimal pregnancy, physiologic birth, postpartum care, and care of the newborn.
GYN Cancer Support Group -
For patients who are diagnosed with a
gynecologic cancer.
In the months after pregnancy, the Baby + Company team provides postpartum care and education, family planning services, screening
for mood disorders, lactation visits, parenting classes, and routine
gynecologic care.
«Although FDA approval is critically important
for introducing a new screening test or algorithm, providers ultimately rely on guidance or guidelines to help them make the best decisions
for their patients and want to understand advantages, disadvantages and unknowns associated with a new screening approach,» said Huh, who is a senior scientist
for the UAB Comprehensive Cancer Center, Director of the UAB Division of
Gynecologic Oncology, and is also a board member
for both the American Society
for Colposcopy and Cervical Pathology and the Society of
Gynecologic Oncology.
Today's guidance, written by a group of cervical cancer screening experts led by University of Alabama at Birmingham
gynecologic oncologist Warner Huh, M.D., is being published simultaneously in the journals Gynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guida
gynecologic oncologist Warner Huh, M.D., is being published simultaneously in the journals
Gynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guida
Gynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing
for Cervical Cancer Screening: Interim Clinical Guidance.»
«If we can demonstrate that the body mounts an immune response to having an IUD placed,
for example, then we could begin investigating whether an IUD can clear a persistent HPV infection in a clinical trial,» explains
gynecologic oncologist and study coauthor Laila Muderspach, MD, chair of obstetrics and gynecology at the Keck School.
«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this research adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of
Gynecologic Oncology, and Executive Director of the Center
for Immunotherapy at Roswell Park.
In the Phase II clinical trial, Dr. Miller and colleagues in the National Cancer Institute - supported
Gynecologic Oncology Group found that in patients who had not received prior chemotherapy, the combination cocktail had a 31 percent response rate
for up to 7 months, and an overall survival of 12 months.
«We found that pemetrexed combined with cisplatin is less toxic, well tolerated, and should be developed
for further treatment of cervical cancer,» said
gynecologic oncology specialist Dr. David Miller, Professor of Obstetrics and Gynecology and a member of the Harold C. Simmons Cancer Center.
Very few studies reported false - positive and false - negative rates
for other
gynecologic conditions.
The USPSTF found inadequate evidence on the benefits of screening
for a range of
gynecologic conditions with pelvic examination.
Very few studies on screening
for other
gynecologic conditions with pelvic examination alone have been conducted, and the USPSTF found that these studies have limited generalizability to the current population of asymptomatic women seen in primary care settings in the United States.
Overall, the USPSTF found inadequate evidence on screening pelvic examinations
for the early detection and treatment of a range of
gynecologic conditions in asymptomatic, nonpregnant adult women.
The U.S. Preventive Services Task Force (USPSTF) has concluded that the current evidence is insufficient to assess the balance of benefits and harms of performing screening pelvic examinations in asymptomatic, nonpregnant adult women
for the early detection and treatment of a range of
gynecologic conditions.
«Hysterectomy is the second most common
gynecologic surgery, and most are done
for benign reasons, because most physicians believe that this surgery has minimal long - term risks,» says Dr. Laughlin - Tommaso.
ACP found that the diagnostic accuracy of the pelvic examination
for detecting
gynecologic cancer or infections is low.
To issue a new recommendation, the USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of performing screening pelvic examinations in asymptomatic, nonpregnant adult women 18 years and older who are not at increased risk
for any specific
gynecologic condition.
More than one - third of counties in the Unites States are located more than 50 miles from the nearest
gynecologic oncologist, making access to specialty care
for ovarian and other
gynecologic cancers difficult
for nearly 15 million women.
Results reveal that all states except North Dakota and Wyoming contain a primary professional address
for at least one
gynecologic oncologist, though all states but three have at least one county further than 50 miles from the closest specialty care center.
«This is the first national study to identify specific regions of the United States where residents may be at an increased risk
for poor clinical outcomes — including misdiagnoses and late detection — as a result of limited access to specialized
gynecologic cancer care,» says David Shalowitz, MD, a fellow in the division of Gynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author on
gynecologic cancer care,» says David Shalowitz, MD, a fellow in the division of
Gynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author on
Gynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author on the study.
Using spatial analysis, the authors determined how many
gynecologic oncologists were located within 50, 100, and 150 miles of county borders
for more than 3,000 counties in the United States.
This study, conducted by the
Gynecologic Oncology Group, a cooperative group funded by the National Cancer Institute, was the second to test bevacizumab under these conditions (first chemotherapy
for platinum - sensitive recurrence), a use
for which bevacizumab is not currently approved by the Food and Drug Administration.
Ovarian cancer accounts
for 5 percent of cancer deaths among women, and causes more deaths than any other
gynecologic cancer.
For women with ovarian cancer, a particularly deadly form of
gynecologic cancer, even improvements in treatment outcomes have been elusive.
«Our algorithm allows us to be much smarter about whom we operate on up front, providing a more individualized approach to surgery that's led to better results
for our patients,» said Anil Sood, M.D., professor of
Gynecologic Oncology and Reproductive Medicine and senior author of the paper.
«Unfortunately, due to the lack of screening mechanisms
for many
gynecologic cancers, they are often diagnosed in an advanced stage, thus leading to poor treatment response with standard therapies in many cases.
Based on these results, two phase 3 trials are being planned
for platinum - sensitive and platinum - resistant ovarian cancer patients by one of NCI's new National Cancer Trial Network Groups, the NRG Oncology Group (formerly 3 cooperative groups: the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the
Gynecologic Oncology Group (GOG).
«We encourage clinical trial participation in the hopes that we will improve the outcome
for our patients with
gynecologic malignancies.»
«We've known
for years that how well a patient does is directly related to the amount of tumor that the surgeon removes and the amount that's left behind,» says Michael Birrer, who began working with Belcher when he was head of medical
gynecologic oncology at Massachusetts General Hospital.
Dr. Kunle Odunsi is the deputy director of the Roswell Park Cancer Institute, where he also serves as the chair of the Department of
Gynecologic Oncology, the executive director of the Center
for Immunotherapy, and the co-Leader of the Tumor Immunology and Immunotherapy research program.
Fellowship training
for physicians in
gynecologic oncology and
gynecologic pathology usually emphasizes clinical care and clinical trials.
For most women who have these
gynecologic cancers, surgery is an important part of the initial treatment and increases the possibility of long - term success.
«Based on a better understanding of its origins, our study suggests new strategies
for the prevention and early detection of ovarian cancer,» senior study author Douglas A. Levine, MD, director of the Division of
Gynecologic Oncology at Perlmutter Cancer Center and professor of obstetrics and gynecology at NYU School of Medicine, tells Medscape.
To learn more about current immunotherapy treatment options
for women with
gynecologic cancers, and how close we are to making these treatments available to more patients, watch Dr. Odunsi's webinar from June 4, 2013.
Both Carpen and Soto were referred to Ghadir Salame, MD, a member of NYU's Perlmutter Cancer Center who has earned a well - regarded reputation among obstetric and
gynecologic colleagues in the New York metro region
for his expertise in treating endometrial cancer using robot - assisted surgery.
Anxiety Disorders Arthritis Breast Cancer Cancer Risk Clinic Delayed Puberty Depression Digestive Diseases Eating Disorders Endometriosis Family Planning
Gynecologic Conditions
Gynecologic Cancers Headaches Heart Disease Incompetent Cervix Incontinence Infertility Lupus Menopause Menstrual Abnormalities Minimally Invasive
Gynecologic Surgery Mixed Connective Tissue Disease Multiple Sclerosis Osteoporosis Pelvic and Vulvar Pain Pelvic Floor Defects Personalized Health & Prevention Plastic Surgery Polycystic Ovary Syndrome (PCOS) Pregnancy Scleroderma Sexual Health
for Female Cancer Patients and Survivors Sexually Transmitted Diseases Skin Problems Thyroid Problems Urinary Incontinence Uterine Fibroids Varicose Veins Weight Loss Surgery Weight Management
For more information about the new study call the
gynecologic oncology research office at 706-721-5557.